AMX-182

N/A

Report date: 2025/11/24 16:31:09

Base Information

Drug NameAMX-182
Drug Alias Nametumor-associated-protease-activated undisclosed target bispecific T-cell engager prodrug (Amunix)AMX-182
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunostimulantsT lymphocytes stimulantsAnti-CD3
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmunix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmunix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A